Back to search

Effects of candesartan cilexetil in patients with severe systemic hypertension

Data up to Jan 2025

Published1999
Citations56
References20

Total Citations Per Year

Abstract

References (20)

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1997 • 5,689 citations

The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1997 • 3,652 citations

The Progression From Hypertension to Congestive Heart Failure

1996 • 2,022 citations

Blood Pressure and End-Stage Renal Disease in Men

1996 • 1,639 citations

The Renin-Angiotensin System

1978 • 969 citations

Pharmacologic Analysis of Drug Receptor Interaction

1988 • 936 citations

Angiotensin Receptors and Their Antagonists

1996 • 568 citations

Pharmacologic analysis of drug-receptor interaction

1995 • 255 citations

Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).

1993 • 211 citations

Hypertension-Related Morbidity and Mortality in the Southeastern United States

1997 • 148 citations

Candesartan Cilexetil

1998 • 141 citations

Candesartan cilexetil, a new generation angiotensin II antagonist, provides dose dependent antihypertensive effect.

1997 • 73 citations

Effects of candesartan cilexetil in patients with systemic hypertension

1998 • 57 citations

Candesartan cilexetil: a review of its preclinical pharmacology.

1997 • 55 citations

Managing the patient with hard-to-control hypertension.

1998 • 51 citations

Combination therapy with diuretics: An evolution of understanding

1996 • 47 citations

The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases.

1995 • 44 citations

Absorption, metabolism and excretion of 14C-candesartan and 14C-candesartan cilexetil in healthy volunteers.

1997 • 43 citations

Twenty-four hour blood pressure profile of different doses of candesartan cilexetil in patients with mild to moderate hypertension.

1997 • 33 citations

Effective dose range of Candesartan cilexetil for systemic hypertension

1999 • 16 citations

Cited By (0)

Loading...
Effects of candesartan cilexetil in patients with severe systemic hypertension (1999) – The American Journal of Cardiology | Metascience Observatory Explorer